s-1743 and atogepant

s-1743 has been researched along with atogepant* in 1 studies

Trials

1 trial(s) available for s-1743 and atogepant

ArticleYear
Evaluation of the pharmacokinetic interactions and safety of atogepant coadministered with esomeprazole.
    Pain management, 2023, Volume: 13, Issue:6

    A clinical study was conducted in 32 healthy adults to evaluate the possibility of interactions between atogepant, a new drug for the prevention of migraine, and esomeprazole, a drug used to reduce stomach acid. The participants of the study were given each drug alone and together to understand the effect they had on the body's ability to absorb, distribute, and excrete each drug alone and together. The results of this study show that there are no clinically important changes in how atogepant is processed by the body when administered with esomeprazole, and they can be safely taken together.

    Topics: Administration, Oral; Adult; Area Under Curve; Cross-Over Studies; Drug Interactions; Esomeprazole; Humans

2023